Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

Neuropsychopharmacology

Volumn 23, Issue 5, 2000, Pages 587-590

  Pollock, Bruce G ^a   Ferrell, Robert E ^b   Mulsant, Benoit H ^a   Mazumdar, Sati ^a   Miller, Mark ^a   Sweet, Robert A ^a   Davis, Stephanie ^a   Kirshner, Margaret A ^a   Houck, Patricia R ^a   Stack, Jacqueline A ^a   Reynolds III, Charles F ^a   Kupfer, David J ^a  

^a GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Late life major depression; Nortriptyline; Paroxetine; Serotonin transporter promoter (5 HTTLPR)

Indexed keywords

NORTRIPTYLINE; PAROXETINE; SEROTONIN TRANSPORTER;

AGED; AGING; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADRENERGIC ALPHA-AGONISTS; AGED; ALLELES; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARRIER PROTEINS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NOREPINEPHRINE; NORTRIPTYLINE; PAROXETINE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033807374     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00132-9     Document Type: Article

References (13)

1. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., Arranz M.J., Murray R.M., Vallada H.P., Bengel D., Muller C.R., Roberts G.W., Smeraldi E., Kirov G., Sham P., Lesch K.P. A novel functional polymorphism within the promoter of the serotonin transporter gene. Possible role in susceptibility to affective disorders Mol Psychiatry. 1:1996;453-460.
2. Edenberg H.J., Reynolds J. Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4). Psychiatric Genetics. 8:1998;193-195.
3. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders SCID I. Clinician Version, Administration Booklet:1997;American Psychiatric Press, Washington, DC.
4. Foglia J.P., Sorisio D., Kirshner M., Pollock B.G. Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection. J Chromatogr Biol Med Appl. 693:1997;147-151.
5. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res. 12:1975;189-198.
6. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
7. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. J Neurochemistry. 66:1996;2621-2624.
8. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
9. Mulsant B.H., Pollock B.G., Nebes R., Miller M., Little J., Stack J., Reynolds C.F. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life. Six-week outcome J Clin Psychiatry. 60(suppl 20):1999;16-20.
10. Pollock B.G., Everett G., Peril J. Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites. Neuropsychopharmacology. 6:1992;1-10.
11. Serretti A., Cusin C., Lattuada E., DiBella D., Catalano M., Smeraldi E. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry. 4:1999;280-283.
12. Smeraldi E., Zanardi R., Benedetti F., Dibella D., Perez J., Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry. 3:1998;508-511.
13. Young RC, Karaviorgou M, Kalayam B, Hull J, Alexopoulos GS (1999): Serotonin transporter promoter polymorphism and response to nortriptyline in geriatric major depression. Society for Neuroscience Meeting, 29th Annual Meeting, Miami Beach, FL. Abstract 533.17.